EDGEWISE THERAPEUTICS INC's ticker is EWTX and the CUSIP is 28036F105. A total of 86 filers reported holding EDGEWISE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 3.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $45,000 | +12.5% | 7,902 | +53.0% | 0.00% | – |
| Q2 2023 | $40,000 | +110.5% | 5,164 | +82.8% | 0.00% | – |
| Q1 2023 | $19,000 | -51.3% | 2,825 | -35.4% | 0.00% | – |
| Q4 2022 | $39,000 | +225.0% | 4,372 | +260.7% | 0.00% | – |
| Q3 2022 | $12,000 | +50.0% | 1,212 | +19.1% | 0.00% | – |
| Q2 2022 | $8,000 | -74.2% | 1,018 | -68.5% | 0.00% | – |
| Q1 2022 | $31,000 | -87.0% | 3,227 | -79.4% | 0.00% | – |
| Q4 2021 | $239,000 | +895.8% | 15,652 | +1017.2% | 0.00% | – |
| Q3 2021 | $24,000 | +33.3% | 1,401 | +66.0% | 0.00% | – |
| Q2 2021 | $18,000 | – | 844 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,553,661 | $15,071,000 | 7.43% |
| Cormorant Asset Management, LP | 4,682,874 | $45,424,000 | 3.49% |
| Novo Holdings A/S | 5,587,207 | $54,196,000 | 2.86% |
| Orbimed Advisors | 13,944,680 | $135,263,000 | 2.19% |
| Opaleye Management Inc. | 303,000 | $2,939,000 | 0.91% |
| DAFNA Capital Management LLC | 356,750 | $3,460,000 | 0.90% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,933,137 | $38,151,000 | 0.85% |
| EcoR1 Capital, LLC | 2,359,808 | $22,890,000 | 0.72% |
| RA Capital Management | 2,613,623 | $25,352,000 | 0.55% |
| HighVista Strategies LLC | 59,733 | $579,000 | 0.37% |